Zentalis Pharmaceuticals, INC. (ZNTL) — SC 13G/A Filings

SC 13G/A Filings (14)

• SC 13G/A Filing — Nov 14, 2024
• SC 13G/A Filing — Nov 12, 2024
• SC 13G/A Filing — Nov 6, 2024
• SC 13G/A Filing — Nov 4, 2024
• SC 13G/A Filing — Oct 18, 2024
• SC 13G/A Filing — Oct 7, 2024
• SC 13G/A Filing — Feb 14, 2024
• SC 13G/A Filing — Feb 13, 2024
• SC 13G/A Filing — Feb 13, 2024
• Capital International Investors Amends Zentalis Pharma Stake — Feb 9, 2024 Risk: low
  Capital International Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, indicating a change in their ownership of Zental
• FMR LLC & Abigail Johnson Maintain 14.6% Stake in Zentalis Pharma — Feb 9, 2024 Risk: low
  FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have filed an amendment to their SC 13G, indicating they collectively beneficiall
• Wellington Management Trims Zentalis Pharma Stake to 7.0% — Feb 9, 2024 Risk: medium
  Wellington Management Group LLP, a major investment firm, filed an amended SC 13G/A on February 9, 2024, indicating a change in their ownership of Zentalis Phar
• BlackRock Amends Zentalis Pharma Stake, Signals Continued Confidence — Jan 29, 2024
  BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating a change in its ownership of Zentalis Pharmaceuticals, Inc. common stock as of December
• State Street Corp. Amends Zentalis Pharma Stake Filing — Jan 25, 2024
  State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Zentalis Pharmaceuticals Inc

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX